1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ARDELYX INC
Ardelyx Inc
XNAS: ARDX
Momentum Trap
Download real time
7.30 0.42 (6.10%)
127.41% Gain from 52W Low
8.1M
XNAS Volume
High volume+gain today

XNAS 04 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert


Insider Trading disclosures for Ardelyx Inc

The latest disclosure was made by Michael G. Raab in Ardelyx Inc where a trade of 20,834 Stock Option (Right to Buy) done was reported to US exchanges on April 15, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Michael G. Raab Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2026 20,834 353,334 - - Stock Option (Right to Buy)
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 6.29 per share. 15 Apr 2026 41,668 1,795,614 (2%) 0% 6.3 261,954 Common Stock
Michael G. Raab Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. 15 Apr 2026 20,834 1,837,282 (2%) 0% 1.0 20,626 Common Stock
Michael G. Raab Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. 16 Mar 2026 20,833 1,856,986 (2%) 0% 1.0 20,625 Common Stock
Michael G. Raab Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2026 20,833 374,168 - - Stock Option (Right to Buy)
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 5.84 per share. 16 Mar 2026 41,666 1,816,448 (2%) 0% 5.8 243,329 Common Stock
Michael G. Raab Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Feb 2026 20,833 395,001 - - Stock Option (Right to Buy)
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 6.26 per share. 24 Feb 2026 41,666 1,836,153 (2%) 0% 6.3 260,621 Common Stock
Michael G. Raab Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. 24 Feb 2026 20,833 1,877,819 (2%) 0% 1.0 20,625 Common Stock
David M. Mott Director Purchase of securities on an exchange or from another person at price $ 5.84 per share. 20 Feb 2026 333,333 3,302,918 (5%) 0% 5.8 1,946,331 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 5.87 per share. 20 Feb 2026 40,401 1,862,567 (2%) 0% 5.9 236,952 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 5.71 per share. 20 Feb 2026 5,576 1,856,991 (2%) 0% 5.7 31,860 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 5.50 per share. 20 Feb 2026 2 1,856,989 (2%) 0% 5.5 11 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 6.00 per share. 20 Feb 2026 1 1,856,988 (2%) 0% 6 6 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 5.50 per share. 20 Feb 2026 2 1,856,986 (2%) 0% 5.5 11 Common Stock
Laura Williams See Remarks Sale of securities on an exchange or to another person at price $ 5.86 per share. 20 Feb 2026 7,192 437,066 (0%) 0% 5.9 42,181 Common Stock
Laura Williams See Remarks Sale of securities on an exchange or to another person at price $ 5.71 per share. 20 Feb 2026 984 436,082 (0%) 0% 5.7 5,622 Common Stock
Eric Duane Foster Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 5.71 per share. 20 Feb 2026 1,261 425,972 (0%) 0% 5.7 7,205 Common Stock
Eric Duane Foster Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 6.00 per share. 20 Feb 2026 1 425,971 (0%) 0% 6 6 Common Stock
Eric Duane Foster Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 6.00 per share. 20 Feb 2026 1 425,970 (0%) 0% 6 6 Common Stock
Eric Duane Foster Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 5.86 per share. 20 Feb 2026 9,176 427,233 (0%) 0% 5.9 53,817 Common Stock
Joseph Reilly See Remarks Sale of securities on an exchange or to another person at price $ 5.50 per share. 20 Feb 2026 2 151,790 (0%) 0% 5.5 11 Common Stock
Joseph Reilly See Remarks Sale of securities on an exchange or to another person at price $ 5.71 per share. 20 Feb 2026 602 151,792 (0%) 0% 5.7 3,440 Common Stock
Joseph Reilly See Remarks Sale of securities on an exchange or to another person at price $ 5.87 per share. 20 Feb 2026 4,387 152,394 (0%) 0% 5.9 25,730 Common Stock
James Parker Brady Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 5.86 per share. 20 Feb 2026 2,234 263,221 (0%) 0% 5.9 13,102 Common Stock
James Parker Brady Chief Human Resources Officer Sale of securities on an exchange or to another person at price $ 5.72 per share. 20 Feb 2026 309 262,912 (0%) 0% 5.7 1,766 Common Stock
Susan Hohenleitner Chief Financial Officer Sale of securities on an exchange or to another person at price $ 5.87 per share. 20 Feb 2026 1,786 230,780 (0%) 0% 5.9 10,475 Common Stock
Susan Hohenleitner Chief Financial Officer Sale of securities on an exchange or to another person at price $ 5.71 per share. 20 Feb 2026 247 230,533 (0%) 0% 5.7 1,411 Common Stock
Michael G. Raab Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2026 669,330 669,330 - - Stock Option (Right to Buy)
Michael G. Raab Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2026 446,220 1,902,968 (2%) 0% 0 Common Stock
Laura Williams Chief Patient Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2026 124,040 124,040 - - Stock Option (Right to Buy)
Laura Williams Chief Patient Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2026 82,695 444,258 (0%) 0% 0 Common Stock
Eric Duane Foster Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2026 137,945 436,409 (0%) 0% 0 Common Stock
Eric Duane Foster Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2026 206,915 206,915 - - Stock Option (Right to Buy)
James Parker Brady Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2026 99,455 265,455 (0%) 0% 0 Common Stock
James Parker Brady Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2026 149,185 149,185 - - Stock Option (Right to Buy)
Susan Hohenleitner Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2026 128,505 128,505 - - Stock Option (Right to Buy)
Susan Hohenleitner Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2026 85,670 232,566 (0%) 0% 0 Common Stock
Joseph Reilly See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2026 46,200 156,781 (0%) 0% 0 Common Stock
Joseph Reilly See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2026 69,360 69,360 - - Stock Option (Right to Buy)
Laura Williams Chief Patient Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. 08 Jan 2026 50,000 409,896 (0%) 0% 1.0 49,500 Common Stock
Laura Williams Chief Patient Officer Sale of securities on an exchange or to another person at price $ 6.98 per share. 08 Jan 2026 50,000 361,563 (0%) 0% 7.0 348,900 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 5.54 per share. 21 Nov 2025 46,887 1,455,363 (2%) 0% 5.5 259,609 Common Stock
Elizabeth Grammer See Remarks 21 Nov 2025 5,995 299,895 (0%) 0% 5.5 33,194 Common Stock
Laura Williams Chief Patient Officer Sale of securities on an exchange or to another person at price $ 5.54 per share. 21 Nov 2025 6,426 359,896 (0%) 0% 5.5 35,580 Common Stock
Eric Duane Foster Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 5.54 per share. 21 Nov 2025 5,814 295,684 (0%) 0% 5.5 32,192 Common Stock
Joseph Reilly See Remarks Sale of securities on an exchange or to another person at price $ 5.54 per share. 21 Nov 2025 11,086 108,914 (0%) 0% 5.5 61,382 Common Stock
Laura Williams Chief Patient Officer Sale of securities on an exchange or to another person at price $ 6.12 per share. 26 Aug 2025 30,000 366,322 (0%) 0% 6.1 183,630 Common Stock
Laura Williams Chief Patient Officer Sale of securities on an exchange or to another person at price $ 6.12 per share. 26 Aug 2025 50,000 396,322 (0%) 0% 6.1 306,050 Common Stock
Laura Williams Chief Patient Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. 26 Aug 2025 50,000 446,322 (0%) 0% 1.0 49,500 Common Stock
Laura Williams Chief Patient Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Aug 2025 50,000 112,000 - - Stock Option (Right to Buy)
Justin A. Renz Chief Financial Officer 21 Aug 2025 7,037 409,052 (0%) 0% 5.9 41,741 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 5.93 per share. 21 Aug 2025 45,687 1,502,250 (2%) 0% 5.9 271,002 Common Stock
Elizabeth Grammer See Remarks 21 Aug 2025 5,841 305,890 (0%) 0% 5.9 34,647 Common Stock
Laura Williams Chief Patient Officer Sale of securities on an exchange or to another person at price $ 5.93 per share. 21 Aug 2025 6,261 396,322 (0%) 0% 5.9 37,138 Common Stock
Eric Duane Foster Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 5.93 per share. 21 Aug 2025 15,308 301,498 (0%) 0% 5.9 90,802 Common Stock
Richard J. Rodgers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 21,468 371,992 (0%) 0% 0 Common Stock
Richard J. Rodgers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 41,551 413,543 (0%) 0% 0 Common Stock
Richard J. Rodgers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 54,059 54,059 - - Stock Option (Right to Buy)
William C. Bertrand Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 54,059 54,059 - - Stock Option (Right to Buy)
William C. Bertrand Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 19,390 249,156 (0%) 0% 0 Common Stock
William C. Bertrand Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 41,551 290,707 (0%) 0% 0 Common Stock
David M. Mott Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 31,163 2,928,034 (4%) 0% 0 Common Stock
David M. Mott Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 41,551 2,969,585 (4%) 0% 0 Common Stock
David M. Mott Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 54,059 54,059 - - Stock Option (Right to Buy)
Robert B. Bazemore Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 54,059 54,059 - - Stock Option (Right to Buy)
Robert B. Bazemore Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 41,551 41,551 (0%) 0% 0 Common Stock
Merdad V. Parsey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 15,235 57,291 (0%) 0% 0 Common Stock
Onaiza Cadoret-Manier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 41,551 151,701 (0%) 0% 0 Common Stock
Onaiza Cadoret-Manier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 54,059 54,059 - - Stock Option (Right to Buy)
Muna Bhanji Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 54,059 54,059 - - Stock Option (Right to Buy)
Muna Bhanji Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 41,551 137,353 (0%) 0% 0 Common Stock
David M. Mott Director Purchase of securities on an exchange or from another person at price $ 3.63 per share. 16 Jun 2025 200,000 2,896,871 (4%) 0% 3.6 725,880 Common Stock
David M. Mott Director Purchase of securities on an exchange or from another person at price $ 3.69 per share. 09 Jun 2025 200,000 2,696,871 (4%) 0% 3.7 737,260 Common Stock
Justin A. Renz Chief Financial Officer 20 May 2025 7,218 416,089 (0%) 0% 4.1 29,460 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 4.08 per share. 20 May 2025 46,817 1,547,937 (2%) 0% 4.1 191,079 Common Stock
Elizabeth Grammer See Remarks 20 May 2025 5,992 311,731 (0%) 0% 4.1 24,456 Common Stock
Laura Williams Chief Medical Officer Sale of securities on an exchange or to another person at price $ 4.08 per share. 20 May 2025 6,421 402,583 (0%) 0% 4.1 26,207 Common Stock
Eric Duane Foster Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 4.08 per share. 20 May 2025 2,507 316,806 (0%) 0% 4.1 10,232 Common Stock
David M. Mott Director Purchase of securities on an exchange or from another person at price $ 3.29 per share. 15 May 2025 100,000 2,496,871 (3%) 0% 3.3 329,120 Common Stock
David M. Mott Director Purchase of securities on an exchange or from another person at price $ 4.22 per share. 02 May 2025 381,377 2,396,871 (3%) 0% 4.2 1,610,936 Common Stock
Michael G. Raab Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. 02 May 2025 20,833 1,636,420 (2%) 0% 1.0 20,625 Common Stock
Michael G. Raab Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 May 2025 20,833 415,834 - - Stock Option (Right to Buy)
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 4.25 per share. 02 May 2025 41,666 1,594,754 (2%) 0% 4.3 177,168 Common Stock
Merdad V. Parsey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2025 42,056 42,056 (0%) 0% 0 Common Stock
Merdad V. Parsey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2025 64,457 64,457 - - Stock Option (Right to Buy)
Michael G. Raab Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. 04 Apr 2025 20,833 1,657,253 (2%) 0% 1.0 20,625 Common Stock
Michael G. Raab Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Apr 2025 20,833 436,667 - - Stock Option (Right to Buy)
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 4.59 per share. 04 Apr 2025 41,666 1,615,587 (2%) 0% 4.6 191,151 Common Stock
Michael G. Raab Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. 07 Mar 2025 20,834 1,676,806 (2%) 0% 1.0 20,626 Common Stock
Michael G. Raab Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Mar 2025 20,834 457,500 - - Stock Option (Right to Buy)
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 5.36 per share. 07 Mar 2025 41,668 1,635,138 (2%) 0% 5.4 223,199 Common Stock
Justin A. Renz Chief Financial Officer 25 Feb 2025 205,019 205,019 - - Stock Option (Right to Buy)
Justin A. Renz Chief Financial Officer 25 Feb 2025 136,680 422,648 (0%) 0% 0 Common Stock
Michael G. Raab Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2025 570,217 1,655,972 (2%) 0% 0 Common Stock
Michael G. Raab Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2025 855,326 855,326 - - Stock Option (Right to Buy)
Elizabeth Grammer See Remarks 25 Feb 2025 205,019 205,019 - - Stock Option (Right to Buy)
Elizabeth Grammer See Remarks 25 Feb 2025 136,680 317,723 (0%) 0% 0 Common Stock
Laura Williams Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2025 157,700 157,700 - - Stock Option (Right to Buy)
Laura Williams Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2025 105,200 409,004 (0%) 0% 0 Common Stock
Eric Duane Foster Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2025 136,680 316,680 (0%) 0% 0 Common Stock
Eric Duane Foster Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2025 205,019 205,019 - - Stock Option (Right to Buy)
David M. Mott Director Purchase of securities on an exchange or from another person at price $ 5.00 per share. 24 Feb 2025 77,729 2,015,494 (3%) 0% 5.0 388,738 Common Stock
Justin A. Renz Chief Financial Officer 20 Feb 2025 5,171 285,968 (0%) 0% 5.6 29,077 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 5.62 per share. 20 Feb 2025 22,964 1,085,755 (1%) 0% 5.6 129,124 Common Stock
Elizabeth Grammer See Remarks 20 Feb 2025 4,291 181,043 (0%) 0% 5.6 24,128 Common Stock
Laura Williams Chief Medical Officer Sale of securities on an exchange or to another person at price $ 5.62 per share. 20 Feb 2025 4,941 303,804 (0%) 0% 5.6 27,783 Common Stock
Michael G. Raab Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Jan 2025 20,833 478,334 - - Stock Option (Right to Buy)
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 5.36 per share. 31 Jan 2025 41,666 1,108,719 (1%) 0% 5.4 223,355 Common Stock
Michael G. Raab Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. 31 Jan 2025 20,833 1,150,385 (1%) 0% 1.0 20,625 Common Stock
David M. Mott Director Purchase of securities on an exchange or from another person at price $ 4.99 per share. 21 Jan 2025 199,000 1,937,765 (2%) 0% 5.0 992,672 Common Stock
Richard J. Rodgers Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.55 per share. 16 Jan 2025 100,000 350,524 (0%) 0% 0.6 55,000 Common Stock
Richard J. Rodgers Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Jan 2025 100,000 0 - - Stock Option (Right to Buy)
Mott M. David Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.55 per share. 26 Dec 2024 100,000 1,738,765 (2%) 0% 0.6 55,000 Common Stock
David Mott M. Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Dec 2024 100,000 0 - - Stock Option (Right to Buy)
David M. Mott Director Purchase of securities on an exchange or from another person at price $ 4.67 per share. 19 Dec 2024 213,300 1,638,765 (2%) 0% 4.7 996,580 Common Stock
Raab Michael G. Director, President & CEO Sale of securities on an exchange or to another person at price $ 5.26 per share. 10 Dec 2024 25,000 1,150,385 (1%) 0% 5.3 131,620 Common Stock
Raab Michael G. Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Dec 2024 25,000 520,000 - - Stock Option (Right to Buy)
Michael G. Raab Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. 10 Dec 2024 25,000 1,175,385 (1%) 0% 1.0 24,750 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 5.38 per share. 25 Nov 2024 25,000 1,150,385 (1%) 0% 5.4 134,483 Common Stock
Justin A. Renz Chief Financial Officer 20 Nov 2024 5,260 291,139 (0%) 0% 4.8 25,219 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 4.79 per share. 20 Nov 2024 31,980 1,175,385 (1%) 0% 4.8 153,328 Common Stock
David P. Rosenbaum Chief Development Officer 20 Nov 2024 4,941 297,005 (0%) 0% 4.8 23,690 Common Stock
David P. Rosenbaum Chief Development Officer 20 Nov 2024 2,243 151,373 (0%) 0% 4.8 10,754 Common Stock
Elizabeth Grammer See Remarks 20 Nov 2024 7,046 185,334 (0%) 0% 4.8 33,782 Common Stock
Robert Blanks See Remarks 20 Nov 2024 4,941 314,421 (0%) 0% 4.8 23,690 Common Stock
Laura Williams Chief Medical Officer Sale of securities on an exchange or to another person at price $ 4.79 per share. 20 Nov 2024 7,366 308,745 (0%) 0% 4.8 35,316 Common Stock
David M. Mott Director Purchase of securities on an exchange or from another person at price $ 4.62 per share. 13 Nov 2024 215,868 1,425,465 (2%) 0% 4.6 996,598 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 4.90 per share. 11 Nov 2024 2,743 1,207,365 (1%) 0% 4.9 13,441 Common Stock
David P. Rosenbaum Chief Development Officer 06 Nov 2024 27,171 180,787 (0%) 0% 2.3 63,037 Common Stock
David P. Rosenbaum Chief Development Officer 06 Nov 2024 27,171 0 - - Stock Option (Right to Buy)
David P. Rosenbaum Chief Development Officer 06 Nov 2024 27,171 153,616 (0%) 0% 6.1 165,743 Common Stock
David P. Rosenbaum Chief Development Officer 04 Nov 2024 27,172 180,788 (0%) 0% 2.3 63,039 Common Stock
David P. Rosenbaum Chief Development Officer 04 Nov 2024 27,172 27,171 - - Stock Option (Right to Buy)
David P. Rosenbaum Chief Development Officer 04 Nov 2024 27,172 153,616 (0%) 0% 5.9 161,673 Common Stock
Michael G. Raab Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. 28 Oct 2024 25,000 1,235,108 (1%) 0% 1.0 24,750 Common Stock
Michael G. Raab Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Oct 2024 25,000 545,000 - - Stock Option (Right to Buy)
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 5.91 per share. 28 Oct 2024 25,000 1,210,108 (1%) 0% 5.9 147,740 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 6.01 per share. 11 Oct 2024 7,500 1,210,108 (1%) 0% 6.0 45,075 Common Stock
David P. Rosenbaum Chief Development Officer 27 Sep 2024 49,564 301,946 (0%) 0% 6.9 342,983 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 6.07 per share. 26 Sep 2024 3,000 1,217,608 (1%) 0% 6.1 18,210 Common Stock
David P. Rosenbaum Chief Development Officer 13 Sep 2024 5,312 153,616 (0%) 0% 6.3 33,254 Common Stock
Michael G. Raab Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. 11 Sep 2024 35,000 1,255,608 (1%) 0% 1.0 34,650 Common Stock
Michael G. Raab Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Sep 2024 35,000 570,000 - - Stock Option (Right to Buy)
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 5.61 per share. 11 Sep 2024 35,000 1,220,608 (1%) 0% 5.6 196,399 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 6.22 per share. 27 Aug 2024 7,500 1,219,509 (1%) 0% 6.2 46,635 Common Stock
Justin A. Renz Chief Financial Officer 20 Aug 2024 5,289 295,257 (0%) 0% 5.9 30,995 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 5.86 per share. 20 Aug 2024 32,225 1,227,009 (1%) 0% 5.9 188,848 Common Stock
David P. Rosenbaum Chief Development Officer 20 Aug 2024 2,250 156,252 (0%) 0% 5.9 13,186 Common Stock
David P. Rosenbaum Chief Development Officer 20 Aug 2024 4,969 351,510 (0%) 0% 5.9 29,120 Common Stock
Elizabeth Grammer See Remarks 20 Aug 2024 7,089 192,380 (0%) 0% 5.9 41,544 Common Stock
Robert Blanks See Remarks 20 Aug 2024 4,969 319,362 (0%) 0% 5.9 29,120 Common Stock
Laura Williams Chief Medical Officer Sale of securities on an exchange or to another person at price $ 5.86 per share. 20 Aug 2024 7,412 314,740 (0%) 0% 5.9 43,437 Common Stock
Robert Felsch See Remarks Sale of securities on an exchange or to another person at price $ 5.86 per share. 20 Aug 2024 3,567 91,560 (0%) 0% 5.9 20,904 Common Stock
David P. Rosenbaum Chief Development Officer 16 Aug 2024 20,507 158,502 (0%) 0% 6 123,042 Common Stock
David P. Rosenbaum Chief Development Officer 16 Aug 2024 20,507 179,009 (0%) 0% 1.0 20,302 Common Stock
David P. Rosenbaum Chief Development Officer 16 Aug 2024 20,000 356,479 (0%) 0% 5.9 118,740 Common Stock
David P. Rosenbaum Chief Development Officer 16 Aug 2024 20,507 49,806 - - Stock Option (Right to Buy)
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 5.71 per share. 12 Aug 2024 1,229 1,259,234 (1%) 0% 5.7 7,018 Common Stock
Eric Duane Foster Chief Commercial Officer 08 Aug 2024 230,000 230,000 - - Stock Option (Right to Buy)
Eric Duane Foster Chief Commercial Officer 08 Aug 2024 180,000 180,000 (0%) 0% 0 Common Stock
Michael G. Raab Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. 29 Jul 2024 30,000 1,290,463 (1%) 0% 1.0 29,700 Common Stock
Michael G. Raab Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Jul 2024 30,000 605,000 - - Stock Option (Right to Buy)
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 5.64 per share. 29 Jul 2024 30,000 1,260,463 (1%) 0% 5.6 169,314 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 5.97 per share. 15 Jul 2024 7,500 1,260,463 (1%) 0% 6.0 44,768 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 6.59 per share. 28 Jun 2024 2,310 1,267,963 (1%) 0% 6.6 15,223 Common Stock
Robert Blanks See Remarks 21 Jun 2024 38,000 324,331 (0%) 0% 6.0 226,290 Common Stock
Richard J. Rodgers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2024 40,243 40,243 - - Stock Option (Right to Buy)
Richard J. Rodgers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2024 12,204 250,524 (0%) 0% 0 Common Stock
William C. Bertrand Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2024 11,023 229,766 (0%) 0% 0 Common Stock
William C. Bertrand Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2024 40,243 40,243 - - Stock Option (Right to Buy)
David M. Mott Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2024 17,322 1,209,597 (1%) 0% 0 Common Stock
David M. Mott Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2024 40,243 40,243 - - Stock Option (Right to Buy)
Robert B. Bazemore Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2024 40,243 40,243 - - Stock Option (Right to Buy)
Onaiza Cadoret-Manier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2024 40,243 40,243 - - Stock Option (Right to Buy)
Muna Bhanji Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2024 40,243 40,243 - - Stock Option (Right to Buy)
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 6.65 per share. 13 Jun 2024 35,000 1,270,273 (1%) 0% 6.6 232,743 Common Stock
Michael G. Raab Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jun 2024 35,000 665,000 - - Stock Option (Right to Buy)
Michael G. Raab Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. 13 Jun 2024 35,000 1,305,273 (1%) 0% 1.0 34,650 Common Stock
Laura Williams Chief Medical Officer Sale of securities on an exchange or to another person at price $ 7.12 per share. 05 Jun 2024 45,000 422,152 (0%) 0% 7.1 320,580 Common Stock
Laura Williams Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Jun 2024 100,000 251,000 - - Stock Option (Right to Buy)
Laura Williams Chief Medical Officer Sale of securities on an exchange or to another person at price $ 7.12 per share. 05 Jun 2024 100,000 322,152 (0%) 0% 7.1 712,500 Common Stock
Laura Williams Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.75 per share. 05 Jun 2024 100,000 467,152 (0%) 0% 2.8 275,000 Common Stock
David P. Rosenbaum Chief Development Officer 03 Jun 2024 17,872 158,502 (0%) 0% 7 125,104 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 6.72 per share. 29 May 2024 7,500 1,270,273 (1%) 0% 6.7 50,390 Common Stock
Justin A. Renz Chief Financial Officer 21 May 2024 5,167 300,546 (0%) 0% 7.8 40,359 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 7.81 per share. 21 May 2024 31,484 1,277,773 (1%) 0% 7.8 245,922 Common Stock
David P. Rosenbaum Chief Development Officer 21 May 2024 4,855 376,479 (0%) 0% 7.8 37,922 Common Stock
David P. Rosenbaum Chief Development Officer 21 May 2024 2,198 176,374 (0%) 0% 7.8 17,169 Common Stock
Elizabeth Grammer See Remarks 21 May 2024 6,927 199,469 (0%) 0% 7.8 54,107 Common Stock
Susan Rodriguez Chief Commercial Officer 21 May 2024 6,703 449,092 (0%) 0% 7.8 52,357 Common Stock
Robert Blanks See Remarks 21 May 2024 4,855 362,331 (0%) 0% 7.8 37,922 Common Stock
Laura Williams Chief Medical Officer Sale of securities on an exchange or to another person at price $ 7.81 per share. 21 May 2024 4,794 367,152 (0%) 0% 7.8 37,446 Common Stock
Robert Felsch See Remarks Sale of securities on an exchange or to another person at price $ 7.81 per share. 21 May 2024 3,485 95,127 (0%) 0% 7.8 27,221 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 7.99 per share. 14 May 2024 3,000 1,307,933 (1%) 0% 8.0 23,970 Common Stock
Elizabeth Grammer See Remarks 06 May 2024 110,250 378,243 (0%) 0% 1.0 109,148 Common Stock
Elizabeth Grammer See Remarks 06 May 2024 109,687 241,313 - - Stock Option (Right to Buy)
Elizabeth Grammer See Remarks 06 May 2024 110,250 85,750 - - Stock Option (Right to Buy)
Elizabeth Grammer See Remarks 06 May 2024 219,937 203,760 (0%) 0% 8.9 1,952,381 Common Stock
Elizabeth Grammer See Remarks 06 May 2024 64,233 423,697 (0%) 0% 8.9 569,837 Common Stock
Elizabeth Grammer See Remarks 06 May 2024 109,687 487,930 (0%) 0% 2.7 301,639 Common Stock
Robert Felsch See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. 06 May 2024 79,101 263,935 (0%) 0% 0.8 66,445 Common Stock
Robert Felsch See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 May 2024 40,000 80,000 - - Stock Option (Right to Buy)
Robert Felsch See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 May 2024 79,101 61,525 - - Stock Option (Right to Buy)
Robert Felsch See Remarks Sale of securities on an exchange or to another person at price $ 8.80 per share. 06 May 2024 55,000 95,947 (0%) 0% 8.8 484,000 Common Stock
Robert Felsch See Remarks Sale of securities on an exchange or to another person at price $ 8.81 per share. 06 May 2024 152,988 150,947 (0%) 0% 8.8 1,347,503 Common Stock
Robert Felsch See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.75 per share. 06 May 2024 40,000 303,935 (0%) 0% 2.8 110,000 Common Stock
Elizabeth Grammer See Remarks 03 May 2024 45,000 267,993 (0%) 0% 9 405,000 Common Stock
Laura Williams Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 May 2024 30,000 162,000 - - Stock Option (Right to Buy)
Laura Williams Chief Medical Officer Sale of securities on an exchange or to another person at price $ 8.35 per share. 03 May 2024 39,949 370,189 (0%) 0% 8.3 333,574 Common Stock
Laura Williams Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. 03 May 2024 30,000 410,138 (0%) 0% 1.0 29,700 Common Stock
Michael G. Raab Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. 29 Apr 2024 30,000 1,340,933 (2%) 0% 1.0 29,700 Common Stock
Michael G. Raab Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Apr 2024 30,000 670,000 - - Stock Option (Right to Buy)
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 6.40 per share. 29 Apr 2024 30,000 1,310,933 (1%) 0% 6.4 192,057 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 7.06 per share. 15 Apr 2024 7,500 1,310,933 (1%) 0% 7.1 52,924 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 7.31 per share. 01 Apr 2024 1,518 1,318,433 (2%) 0% 7.3 11,097 Common Stock
Elizabeth Grammer See Remarks 20 Mar 2024 86,000 312,993 (0%) 0% 7.7 664,978 Common Stock
Robert Blanks See Remarks 15 Mar 2024 1,000 367,186 (0%) 0% 0 Common Stock
P. David Rosenbaum Chief Development Officer 26 Feb 2024 5,183 175,936 (0%) 0% 9.2 47,684 Common Stock
Laura Williams Chief Medical Officer Sale of securities on an exchange or to another person at price $ 8.75 per share. 20 Feb 2024 4,803 380,138 (0%) 0% 8.7 42,008 Common Stock
Blanks Robert See Remarks 20 Feb 2024 5,017 368,186 (0%) 0% 8.7 43,880 Common Stock
P. David Rosenbaum Chief Development Officer 20 Feb 2024 5,017 378,985 (0%) 0% 8.7 43,880 Common Stock
A. Justin Renz Chief Financial Officer 20 Feb 2024 5,341 304,835 (0%) 0% 8.7 46,714 Common Stock
David P. Rosenbaum Chief Development Officer 20 Feb 2024 2,294 181,119 (0%) 0% 8.7 20,064 Common Stock
Felsch Robert See Remarks Sale of securities on an exchange or to another person at price $ 8.75 per share. 20 Feb 2024 2,352 184,834 (0%) 0% 8.7 20,571 Common Stock
Elizabeth Grammer See Remarks 20 Feb 2024 4,432 398,993 (0%) 0% 8.7 38,764 Common Stock
Michael Raab G. Director, President & CEO Sale of securities on an exchange or to another person at price $ 8.75 per share. 20 Feb 2024 22,917 1,319,951 (2%) 0% 8.7 200,439 Common Stock
Rodriguez Susan Chief Commercial Officer 20 Feb 2024 6,928 452,795 (0%) 0% 8.7 60,594 Common Stock
Rosenbaum David P. Chief Development Officer 08 Feb 2024 15,344 384,002 (0%) 0% 9.2 140,846 Common Stock
Williams Laura Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2024 152,127 152,127 - - Stock Option (Right to Buy)
Susan Rodriguez Chief Commercial Officer 16 Jan 2024 112,750 459,723 (0%) 0% 0 Common Stock
Robert Blanks See Remarks 16 Jan 2024 112,750 373,203 (0%) 0% 0 Common Stock
Michael G. Raab Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2024 475,000 1,342,868 (2%) 0% 0 Common Stock
Elizabeth Grammer See Remarks 16 Jan 2024 164,000 164,000 - - Stock Option (Right to Buy)
Rodriguez Susan Chief Commercial Officer 16 Jan 2024 145,000 145,000 - - Stock Option (Right to Buy)
A. Renz Justin Chief Financial Officer 16 Jan 2024 127,750 310,176 (0%) 0% 0 Common Stock
Laura Williams Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2024 118,750 384,941 (0%) 0% 0 Common Stock
Rosenbaum P. David Chief Development Officer 16 Jan 2024 70,120 183,413 (0%) 0% 0 Common Stock
Felsch Robert See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2024 70,120 187,186 (0%) 0% 0 Common Stock
Michael Raab G. Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2024 605,904 605,904 - - Stock Option (Right to Buy)
Felsch Robert See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2024 99,000 99,000 - - Stock Option (Right to Buy)
Robert Blanks See Remarks 16 Jan 2024 145,000 145,000 - - Stock Option (Right to Buy)
Grammer Elizabeth See Remarks 16 Jan 2024 127,750 403,425 (0%) 0% 0 Common Stock
A. Justin Renz Chief Financial Officer 16 Jan 2024 164,000 164,000 - - Stock Option (Right to Buy)
P. David Rosenbaum Chief Development Officer 16 Jan 2024 145,000 145,000 - - Stock Option (Right to Buy)
Rosenbaum P. David Chief Development Officer 16 Jan 2024 112,750 399,346 (0%) 0% 0 Common Stock
P. David Rosenbaum Chief Development Officer 16 Jan 2024 99,000 99,000 - - Stock Option (Right to Buy)
David P. Rosenbaum Chief Development Officer 08 Jan 2024 30,000 286,596 (0%) 0% 6.6 199,200 Common Stock
A. Justin Renz Chief Financial Officer 26 Dec 2023 75,000 121,000 - - Stock Option (Right to Buy)
Renz A. Justin Chief Financial Officer 26 Dec 2023 225,000 182,426 (0%) 0% 6.4 1,430,123 Common Stock
A. Renz Justin Chief Financial Officer 26 Dec 2023 75,000 407,426 (0%) 0% 1.0 74,250 Common Stock
David P. Rosenbaum Chief Development Officer 18 Dec 2023 5,675 316,596 (0%) 0% 6.1 34,447 Common Stock
David P. Rosenbaum Chief Development Officer 14 Dec 2023 7,000 322,271 (0%) 0% 5.6 38,850 Common Stock
Grammer Elizabeth See Remarks 11 Dec 2023 50,000 275,675 (0%) 0% 5.1 253,925 Common Stock
David Rosenbaum P. Chief Development Officer 08 Dec 2023 20,000 329,271 (0%) 0% 5.3 105,476 Common Stock
Justin A. Renz Chief Financial Officer 21 Aug 2023 2,884 333,849 (0%) 0% 3.6 10,243 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 3.55 per share. 21 Aug 2023 11,419 876,236 (1%) 0% 3.6 40,558 Common Stock
David P. Rosenbaum Chief Development Officer 21 Aug 2023 2,846 369,919 (0%) 0% 3.6 10,108 Common Stock
David P. Rosenbaum Chief Development Officer 21 Aug 2023 937 111,225 (0%) 0% 3.6 3,328 Common Stock
Elizabeth Grammer See Remarks 21 Aug 2023 2,392 328,059 (0%) 0% 3.6 8,496 Common Stock
Susan Rodriguez Chief Commercial Officer 21 Aug 2023 4,733 348,687 (0%) 0% 3.6 16,811 Common Stock
Robert Blanks See Remarks 21 Aug 2023 2,846 263,288 (0%) 0% 3.6 10,108 Common Stock
Laura Williams Chief Medical Officer Sale of securities on an exchange or to another person at price $ 3.55 per share. 21 Aug 2023 2,591 291,839 (0%) 0% 3.6 9,203 Common Stock
Robert Felsch See Remarks Sale of securities on an exchange or to another person at price $ 3.55 per share. 21 Aug 2023 1,048 115,110 (0%) 0% 3.6 3,722 Common Stock
Laura Williams Chief Medical Officer Sale of securities on an exchange or to another person at price $ 3.35 per share. 27 Jun 2023 25,000 294,430 (0%) 0% 3.3 83,633 Common Stock
Richard J. Rodgers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 18,494 238,320 (0%) 0% 0 Common Stock
Richard J. Rodgers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 49,237 49,237 - - Stock Option (Right to Buy)
William C. Bertrand Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 16,581 218,743 (0%) 0% 0 Common Stock
William C. Bertrand Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 49,237 49,237 - - Stock Option (Right to Buy)
David M. Mott Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 49,237 49,237 - - Stock Option (Right to Buy)
David M. Mott Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 25,510 1,192,275 (1%) 0% 0 Common Stock
Jan M. Lundberg Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 12,755 146,794 (0%) 0% 0 Common Stock
Jan M. Lundberg Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 49,237 49,237 - - Stock Option (Right to Buy)
Robert B. Bazemore Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 49,237 49,237 - - Stock Option (Right to Buy)
Geoffrey A. Block Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 49,237 49,237 - - Stock Option (Right to Buy)
Onaiza Cadoret-Manier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 12,755 110,150 (0%) 0% 0 Common Stock
Onaiza Cadoret-Manier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 49,237 49,237 - - Stock Option (Right to Buy)
Muna Bhanji Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 49,237 49,237 - - Stock Option (Right to Buy)
Justin A. Renz Chief Financial Officer 23 May 2023 2,873 336,733 (0%) 0% 3.7 10,496 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 3.65 per share. 23 May 2023 11,357 887,655 (1%) 0% 3.7 41,489 Common Stock
David P. Rosenbaum Chief Development Officer 23 May 2023 934 112,162 (0%) 0% 3.7 3,412 Common Stock
David P. Rosenbaum Chief Development Officer 23 May 2023 2,835 372,765 (0%) 0% 3.7 10,357 Common Stock
Elizabeth Grammer See Remarks 23 May 2023 2,384 330,451 (0%) 0% 3.7 8,709 Common Stock
Susan Rodriguez Chief Commercial Officer 23 May 2023 4,711 353,420 (0%) 0% 3.7 17,210 Common Stock
Robert Blanks See Remarks 23 May 2023 2,835 266,134 (0%) 0% 3.7 10,357 Common Stock
Laura Williams Chief Medical Officer Sale of securities on an exchange or to another person at price $ 3.65 per share. 23 May 2023 2,583 319,430 (0%) 0% 3.7 9,436 Common Stock
Robert Felsch See Remarks Sale of securities on an exchange or to another person at price $ 3.65 per share. 23 May 2023 1,046 116,158 (0%) 0% 3.7 3,821 Common Stock
David P. Rosenbaum Chief Development Officer 29 Mar 2023 3,000 113,096 (0%) 0% 4.6 13,888 Common Stock
Justin A. Renz Chief Financial Officer 21 Feb 2023 3,439 336,606 (0%) 0% 3.0 10,320 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 3.00 per share. 21 Feb 2023 13,449 896,012 (1%) 0% 3.0 40,360 Common Stock
David P. Rosenbaum Chief Development Officer 21 Feb 2023 3,394 375,600 (0%) 0% 3.0 10,185 Common Stock
David P. Rosenbaum Chief Development Officer 21 Feb 2023 1,114 113,096 (0%) 0% 3.0 3,343 Common Stock
Elizabeth Grammer See Remarks 21 Feb 2023 2,914 329,954 (0%) 0% 3.0 8,745 Common Stock
Susan Rodriguez Chief Commercial Officer 21 Feb 2023 5,586 355,131 (0%) 0% 3.0 16,764 Common Stock
Robert Blanks See Remarks 21 Feb 2023 3,394 268,969 (0%) 0% 3.0 10,185 Common Stock
Laura Williams Chief Medical Officer Sale of securities on an exchange or to another person at price $ 3.00 per share. 21 Feb 2023 3,187 319,013 (0%) 0% 3.0 9,564 Common Stock
Robert Felsch See Remarks Sale of securities on an exchange or to another person at price $ 3.00 per share. 21 Feb 2023 3,214 114,204 (0%) 0% 3.0 9,645 Common Stock
Justin A. Renz Chief Financial Officer 05 Jan 2023 78,000 340,045 (0%) 0% 0 Common Stock
Justin A. Renz Chief Financial Officer 05 Jan 2023 351,000 351,000 - - Stock Option (Right to Buy)
Michael G. Raab Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2023 1,124,000 1,124,000 - - Stock Option (Right to Buy)
Michael G. Raab Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2023 250,000 909,461 (1%) 0% 0 Common Stock
David P. Rosenbaum Chief Development Officer 05 Jan 2023 25,325 114,210 (0%) 0% 0 Common Stock
David P. Rosenbaum Chief Development Officer 05 Jan 2023 78,000 378,994 (0%) 0% 0 Common Stock
David P. Rosenbaum Chief Development Officer 05 Jan 2023 116,250 116,250 - - Stock Option (Right to Buy)
David P. Rosenbaum Chief Development Officer 05 Jan 2023 351,000 351,000 - - Stock Option (Right to Buy)
Elizabeth Grammer See Remarks 05 Jan 2023 351,000 351,000 - - Stock Option (Right to Buy)
Elizabeth Grammer See Remarks 05 Jan 2023 78,000 332,868 (0%) 0% 0 Common Stock
Susan Rodriguez Chief Commercial Officer 05 Jan 2023 351,000 351,000 - - Stock Option (Right to Buy)
Susan Rodriguez Chief Commercial Officer 05 Jan 2023 78,000 360,717 (0%) 0% 0 Common Stock
Robert Blanks See Remarks 05 Jan 2023 78,000 272,363 (0%) 0% 0 Common Stock
Robert Blanks See Remarks 05 Jan 2023 351,000 351,000 - - Stock Option (Right to Buy)
Laura Williams Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2023 351,000 351,000 - - Stock Option (Right to Buy)
Laura Williams Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2023 78,000 322,200 (0%) 0% 0 Common Stock
Robert Felsch See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2023 26,000 117,418 (0%) 0% 0 Common Stock
Robert Felsch See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2023 120,000 120,000 - - Stock Option (Right to Buy)
Justin A. Renz Chief Financial Officer 22 Nov 2022 1,443 262,045 (0%) 0% 1.9 2,813 Common Stock
Justin A. Renz Chief Financial Officer 22 Nov 2022 61 263,488 (0%) 0% 1.9 118 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 1.94 per share. 22 Nov 2022 162 665,518 (1%) 0% 1.9 314 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 1.95 per share. 22 Nov 2022 5,936 659,461 (1%) 0% 1.9 11,571 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 1.94 per share. 22 Nov 2022 121 665,397 (1%) 0% 1.9 235 Common Stock
David P. Rosenbaum Chief Development Officer 22 Nov 2022 2 89,356 (0%) 0% 2 4 Common Stock
David P. Rosenbaum Chief Development Officer 22 Nov 2022 11 89,358 (0%) 0% 1.9 21 Common Stock
David P. Rosenbaum Chief Development Officer 22 Nov 2022 1,405 300,994 (0%) 0% 1.9 2,739 Common Stock
David P. Rosenbaum Chief Development Officer 22 Nov 2022 33 302,399 (0%) 0% 1.9 64 Common Stock
David P. Rosenbaum Chief Development Officer 22 Nov 2022 26 302,432 (0%) 0% 1.9 50 Common Stock
David P. Rosenbaum Chief Development Officer 22 Nov 2022 471 88,885 (0%) 0% 1.9 918 Common Stock
Elizabeth Grammer See Remarks 22 Nov 2022 1,193 254,868 (0%) 0% 1.9 2,326 Common Stock
Elizabeth Grammer See Remarks 22 Nov 2022 29 256,081 (0%) 0% 1.9 56 Common Stock
Elizabeth Grammer See Remarks 22 Nov 2022 20 256,061 (0%) 0% 2.0 39 Common Stock
Susan Rodriguez Chief Commercial Officer 22 Nov 2022 131 286,042 (0%) 0% 1.9 254 Common Stock
Susan Rodriguez Chief Commercial Officer 22 Nov 2022 3,303 282,717 (0%) 0% 1.9 6,439 Common Stock
Susan Rodriguez Chief Commercial Officer 22 Nov 2022 22 286,020 (0%) 0% 2.0 43 Common Stock
Robert Blanks See Remarks 22 Nov 2022 1,405 194,363 (0%) 0% 1.9 2,739 Common Stock
Robert Blanks See Remarks 22 Nov 2022 26 195,768 (0%) 0% 1.9 50 Common Stock
Robert Blanks See Remarks 22 Nov 2022 33 195,794 (0%) 0% 1.9 64 Common Stock
Laura Williams Chief Medical Officer Sale of securities on an exchange or to another person at price $ 1.93 per share. 22 Nov 2022 15 245,426 (0%) 0% 1.9 29 Common Stock
Laura Williams Chief Medical Officer Sale of securities on an exchange or to another person at price $ 1.94 per share. 22 Nov 2022 33 245,393 (0%) 0% 1.9 64 Common Stock
Laura Williams Chief Medical Officer Sale of securities on an exchange or to another person at price $ 1.95 per share. 22 Nov 2022 1,193 244,200 (0%) 0% 1.9 2,326 Common Stock
David M. Mott Director Purchase of securities on an exchange or from another person at price $ 1.76 per share. 17 Nov 2022 567,000 1,166,765 (1%) 0% 1.8 1,000,642 Common Stock
Robert Blanks See Remarks 05 Oct 2022 100,000 195,827 (0%) 0% 1.5 150,000 Common Stock
Justin A. Renz Chief Financial Officer 31 Aug 2022 3,000 263,549 (0%) 0% 0.6 1,856 Common Stock
Michael G. Raab Director, President & CEO Purchase of securities on an exchange or from another person at price $ 0.62 per share. 31 Aug 2022 3,000 665,680 (1%) 0% 0.6 1,856 Common Stock
David P. Rosenbaum Chief Development Officer 31 Aug 2022 3,000 89,369 (0%) 0% 0.9 2,760 Common Stock
David P. Rosenbaum Chief Development Officer 31 Aug 2022 3,000 92,369 (0%) 0% 0.6 1,856 Common Stock
Elizabeth Grammer See Remarks 31 Aug 2022 3,000 256,110 (0%) 0% 0.6 1,856 Common Stock
Laura Williams Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 0.62 per share. 31 Aug 2022 3,000 245,441 (0%) 0% 0.6 1,856 Common Stock
Robert Felsch See Remarks Purchase of securities on an exchange or from another person at price $ 0.62 per share. 31 Aug 2022 3,000 91,418 (0%) 0% 0.6 1,856 Common Stock
Robert Blanks See Remarks 26 Aug 2022 21,842 295,827 (0%) 0% 1.0 22,713 Common Stock
Justin A. Renz Chief Financial Officer 22 Aug 2022 6 260,561 (0%) 0% 1 6 Common Stock
Justin A. Renz Chief Financial Officer 22 Aug 2022 12 260,549 (0%) 0% 1 12 Common Stock
Justin A. Renz Chief Financial Officer 22 Aug 2022 1,480 260,567 (0%) 0% 1.0 1,456 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.98 per share. 22 Aug 2022 54 662,756 (1%) 0% 1.0 53 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.98 per share. 22 Aug 2022 6,016 662,810 (1%) 0% 1.0 5,918 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.97 per share. 22 Aug 2022 76 662,680 (1%) 0% 1.0 74 Common Stock
David P. Rosenbaum Chief Development Officer 22 Aug 2022 1 89,369 (0%) 0% 1 1 Common Stock
David P. Rosenbaum Chief Development Officer 22 Aug 2022 496 89,370 (0%) 0% 1.0 488 Common Stock
David P. Rosenbaum Chief Development Officer 22 Aug 2022 17 302,458 (0%) 0% 1 17 Common Stock
David P. Rosenbaum Chief Development Officer 22 Aug 2022 1,441 302,475 (0%) 0% 1.0 1,418 Common Stock
Elizabeth Grammer See Remarks 22 Aug 2022 9 253,110 (0%) 0% 1 9 Common Stock
Elizabeth Grammer See Remarks 22 Aug 2022 2 253,119 (0%) 0% 1 2 Common Stock
Elizabeth Grammer See Remarks 22 Aug 2022 1,225 253,121 (0%) 0% 1.0 1,205 Common Stock
Susan Rodriguez Chief Commercial Officer 22 Aug 2022 64 286,173 (0%) 0% 1.0 63 Common Stock
Susan Rodriguez Chief Commercial Officer 22 Aug 2022 3,356 286,237 (0%) 0% 1.0 3,301 Common Stock
Robert Blanks See Remarks 22 Aug 2022 1,441 317,686 (0%) 0% 1.0 1,418 Common Stock
Robert Blanks See Remarks 22 Aug 2022 17 317,669 (0%) 0% 1 17 Common Stock
Laura Williams Chief Medical Officer Sale of securities on an exchange or to another person at price $ 0.98 per share. 22 Aug 2022 1,263 242,454 (0%) 0% 1.0 1,242 Common Stock
Laura Williams Chief Medical Officer Sale of securities on an exchange or to another person at price $ 1.00 per share. 22 Aug 2022 13 242,441 (0%) 0% 1 13 Common Stock
Robert Blanks See Remarks 26 Jul 2022 5,188 319,127 (0%) 0% 0.7 3,476 Common Stock
Richard J. Rodgers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2022 132,299 219,826 (0%) 0% 0 Common Stock
Richard J. Rodgers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2022 100,000 100,000 - - Stock Option (Right to Buy)
William C. Bertrand Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2022 118,613 202,162 (0%) 0% 0 Common Stock
William C. Bertrand Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2022 100,000 100,000 - - Stock Option (Right to Buy)
David M. Mott Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2022 182,481 599,765 (0%) 0% 0 Common Stock
David M. Mott Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2022 100,000 100,000 - - Stock Option (Right to Buy)
Jan M. Lundberg Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2022 91,240 134,039 (0%) 0% 0 Common Stock
Jan M. Lundberg Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2022 100,000 100,000 - - Stock Option (Right to Buy)
Robert B. Bazemore Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2022 100,000 100,000 - - Stock Option (Right to Buy)
Geoffrey A. Block Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2022 100,000 100,000 - - Stock Option (Right to Buy)
Onaiza Cadoret-Manier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2022 91,240 97,395 (0%) 0% 0 Common Stock
Onaiza Cadoret-Manier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2022 100,000 100,000 - - Stock Option (Right to Buy)
Muna Bhanji Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2022 100,000 100,000 - - Stock Option (Right to Buy)
Muna Bhanji Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2022 95,802 95,802 (0%) 0% 0 Common Stock
Justin A. Renz Chief Financial Officer 06 Jun 2022 1,518 262,047 (0%) 0% 0.6 965 Common Stock
Justin A. Renz Chief Financial Officer 06 Jun 2022 71,794 263,565 (0%) 0% 0.7 46,731 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.64 per share. 06 Jun 2022 2,144 668,826 (1%) 0% 0.6 1,363 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.65 per share. 06 Jun 2022 101,480 670,970 (1%) 0% 0.7 66,053 Common Stock
David P. Rosenbaum Chief Development Officer 06 Jun 2022 366 89,866 (0%) 0% 0.6 233 Common Stock
David P. Rosenbaum Chief Development Officer 06 Jun 2022 43,093 304,827 (0%) 0% 0.7 28,049 Common Stock
David P. Rosenbaum Chief Development Officer 06 Jun 2022 911 303,916 (0%) 0% 0.6 579 Common Stock
David P. Rosenbaum Chief Development Officer 06 Jun 2022 17,270 90,232 (0%) 0% 0.7 11,241 Common Stock
Elizabeth Grammer See Remarks 06 Jun 2022 1,260 254,346 (0%) 0% 0.6 801 Common Stock
Elizabeth Grammer See Remarks 06 Jun 2022 59,561 255,606 (0%) 0% 0.7 38,768 Common Stock
Susan Rodriguez Chief Commercial Officer 06 Jun 2022 43,010 290,503 (0%) 0% 0.7 27,995 Common Stock
Susan Rodriguez Chief Commercial Officer 06 Jun 2022 910 289,593 (0%) 0% 0.6 578 Common Stock
Robert Blanks See Remarks 06 Jun 2022 1,517 324,315 (0%) 0% 0.6 964 Common Stock
Robert Blanks See Remarks 06 Jun 2022 71,795 325,832 (0%) 0% 0.7 46,731 Common Stock
Justin A. Renz Chief Financial Officer 20 May 2022 1,528 335,359 (0%) 0% 0.7 1,026 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.67 per share. 20 May 2022 6,124 772,450 (1%) 0% 0.7 4,112 Common Stock
David P. Rosenbaum Chief Development Officer 20 May 2022 1,489 347,920 (0%) 0% 0.7 1,000 Common Stock
David P. Rosenbaum Chief Development Officer 20 May 2022 524 107,502 (0%) 0% 0.7 352 Common Stock
Elizabeth Grammer See Remarks 20 May 2022 1,263 315,167 (0%) 0% 0.7 848 Common Stock
Susan Rodriguez Chief Commercial Officer 20 May 2022 3,425 333,513 (0%) 0% 0.7 2,300 Common Stock
Robert Blanks See Remarks 20 May 2022 1,489 397,627 (0%) 0% 0.7 1,000 Common Stock
Justin A. Renz Chief Financial Officer 22 Feb 2022 1,800 333,887 (0%) 0% 0.7 1,206 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.67 per share. 22 Feb 2022 6,229 775,574 (1%) 0% 0.7 4,173 Common Stock
David P. Rosenbaum Chief Development Officer 22 Feb 2022 1,752 349,409 (0%) 0% 0.7 1,174 Common Stock
David P. Rosenbaum Chief Development Officer 22 Feb 2022 601 105,026 (0%) 0% 0.7 403 Common Stock
Susan Rodriguez Chief Commercial Officer 22 Feb 2022 3,400 333,938 (0%) 0% 0.7 2,278 Common Stock
Robert Blanks See Remarks 22 Feb 2022 1,752 399,116 (0%) 0% 0.7 1,174 Common Stock
Justin A. Renz Chief Financial Officer 06 Jan 2022 42,000 335,687 (0%) 0% 0 Common Stock
Justin A. Renz Chief Financial Officer 06 Jan 2022 196,000 196,000 - - Stock Option (Right to Buy)
Michael G. Raab Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2022 150,000 781,803 (1%) 0% 0 Common Stock
Michael G. Raab Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2022 700,000 700,000 - - Stock Option (Right to Buy)
David P. Rosenbaum Chief Development Officer 06 Jan 2022 70,313 70,313 - - Stock Option (Right to Buy)
David P. Rosenbaum Chief Development Officer 06 Jan 2022 190,000 190,000 - - Stock Option (Right to Buy)
David P. Rosenbaum Chief Development Officer 06 Jan 2022 15,000 105,627 (0%) 0% 0 Common Stock
David P. Rosenbaum Chief Development Officer 06 Jan 2022 40,000 351,161 (0%) 0% 0 Common Stock
Elizabeth Grammer See Remarks 06 Jan 2022 196,000 196,000 - - Stock Option (Right to Buy)
Elizabeth Grammer See Remarks 06 Jan 2022 42,000 317,958 (0%) 0% 0 Common Stock
Susan Rodriguez Chief Commercial Officer 06 Jan 2022 195,000 195,000 - - Stock Option (Right to Buy)
Susan Rodriguez Chief Commercial Officer 06 Jan 2022 141,000 338,031 (0%) 0% 0 Common Stock
Robert Blanks See Remarks 06 Jan 2022 190,000 190,000 - - Stock Option (Right to Buy)
Robert Blanks See Remarks 06 Jan 2022 40,000 400,868 (0%) 0% 0 Common Stock
Forest Baskett Ten Percent Owner Sale of securities on an exchange or to another person at price $ 1.24 per share. 09 Dec 2021 216,049 2,582,017 (3%) 0% 1.2 268,787 Common Stock
Forest Baskett Ten Percent Owner Sale of securities on an exchange or to another person at price $ 1.24 per share. 09 Dec 2021 191,074 2,285,682 (3%) 0% 1.2 237,715 Common Stock
Forest Baskett Ten Percent Owner Sale of securities on an exchange or to another person at price $ 1.24 per share. 09 Dec 2021 593,612 7,095,665 (10%) 0% 1.2 738,513 Common Stock
Forest Baskett Ten Percent Owner Sale of securities on an exchange or to another person at price $ 1.51 per share. 09 Dec 2021 144,533 2,798,066 (4%) 0% 1.5 218,664 Common Stock
Forest Baskett Ten Percent Owner Sale of securities on an exchange or to another person at price $ 1.51 per share. 09 Dec 2021 397,124 7,689,277 (11%) 0% 1.5 600,809 Common Stock
Sandell D Scott Ten Percent Owner Sale of securities on an exchange or to another person at price $ 1.51 per share. 09 Dec 2021 397,124 7,689,277 (11%) 0% 1.5 600,809 Common Stock
Sandell D Scott Ten Percent Owner Sale of securities on an exchange or to another person at price $ 1.14 per share. 09 Dec 2021 323,167 2,258,850 (3%) 0% 1.1 369,412 Common Stock
Sandell D Scott Ten Percent Owner Sale of securities on an exchange or to another person at price $ 1.14 per share. 09 Dec 2021 888,185 6,207,480 (9%) 1% 1.1 1,015,284 Common Stock
Sandell D Scott Ten Percent Owner Sale of securities on an exchange or to another person at price $ 1.24 per share. 09 Dec 2021 216,049 2,582,017 (3%) 0% 1.2 268,787 Common Stock
Sandell D Scott Ten Percent Owner Sale of securities on an exchange or to another person at price $ 1.24 per share. 09 Dec 2021 191,074 2,285,682 (3%) 0% 1.2 237,715 Common Stock
Sandell D Scott Ten Percent Owner Sale of securities on an exchange or to another person at price $ 1.24 per share. 09 Dec 2021 593,612 7,095,665 (10%) 0% 1.2 738,513 Common Stock
Sandell D Scott Ten Percent Owner Sale of securities on an exchange or to another person at price $ 1.51 per share. 09 Dec 2021 144,533 2,798,066 (4%) 0% 1.5 218,664 Common Stock
Sandell D Scott Ten Percent Owner Sale of securities on an exchange or to another person at price $ 1.51 per share. 09 Dec 2021 127,826 2,476,756 (3%) 0% 1.5 193,388 Common Stock
Forest Baskett Ten Percent Owner Sale of securities on an exchange or to another person at price $ 1.51 per share. 09 Dec 2021 127,826 2,476,756 (3%) 0% 1.5 193,388 Common Stock
Forest Baskett Ten Percent Owner Sale of securities on an exchange or to another person at price $ 1.14 per share. 09 Dec 2021 323,167 2,258,850 (3%) 0% 1.1 369,412 Common Stock
Forest Baskett Ten Percent Owner Sale of securities on an exchange or to another person at price $ 1.14 per share. 09 Dec 2021 888,185 6,207,480 (9%) 1% 1.1 1,015,284 Common Stock
Justin A. Renz Chief Financial Officer 22 Nov 2021 643 293,687 (0%) 0% 1.0 638 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 0.99 per share. 22 Nov 2021 2,607 631,803 (0%) 0% 1.0 2,586 Common Stock
David P. Rosenbaum Chief Development Officer 22 Nov 2021 184 90,627 (0%) 0% 1.0 182 Common Stock
David P. Rosenbaum Chief Development Officer 22 Nov 2021 643 311,161 (0%) 0% 1.0 638 Common Stock
Jeffrey Jacobs Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.99 per share. 22 Nov 2021 754 119,483 (0%) 0% 1.0 748 Common Stock
Jeffrey Jacobs Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.98 per share. 22 Nov 2021 5,000 120,237 (0%) 0% 1.0 4,882 Common Stock
Elizabeth Grammer See Remarks 22 Nov 2021 537 275,958 (0%) 0% 1.0 533 Common Stock
Susan Rodriguez Chief Commercial Officer 22 Nov 2021 643 197,030 (0%) 0% 1.0 638 Common Stock
Robert Blanks See Remarks 22 Nov 2021 643 360,868 (0%) 0% 1.0 638 Common Stock
Jeffrey Jacobs Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 1.13 per share. 15 Nov 2021 5,000 125,237 (0%) 0% 1.1 5,650 Common Stock
Jeffrey Jacobs Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 1.18 per share. 08 Nov 2021 2,166 130,237 (0%) 0% 1.2 2,556 Common Stock
Justin A. Renz Chief Financial Officer 20 Aug 2021 631 40,047 (0%) 0% 1.3 833 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 1.32 per share. 20 Aug 2021 2,573 329,730 (0%) 0% 1.3 3,396 Common Stock
David P. Rosenbaum Chief Development Officer 20 Aug 2021 176 26,574 (0%) 0% 1.3 232 Common Stock
David P. Rosenbaum Chief Development Officer 20 Aug 2021 631 158,804 (0%) 0% 1.3 833 Common Stock
Jeffrey Jacobs Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 1.32 per share. 20 Aug 2021 741 127,697 (0%) 0% 1.3 978 Common Stock
Elizabeth Grammer See Remarks 20 Aug 2021 526 102,386 (0%) 0% 1.3 694 Common Stock
Susan Rodriguez Chief Commercial Officer 20 Aug 2021 630 44,673 (0%) 0% 1.3 832 Common Stock
Robert Blanks See Remarks 20 Aug 2021 631 106,323 (0%) 0% 1.3 833 Common Stock
Michael G. Raab Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.64 per share. 03 Aug 2021 150,343 332,303 (0%) 0% 1.6 246,563 Common Stock
Michael G. Raab Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. 03 Aug 2021 267,892 482,646 (0%) 0% 0.5 144,662 Common Stock
Michael G. Raab Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Aug 2021 267,892 0 - - Stock Option (Right to Buy)
Jeffrey Jacobs Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Aug 2021 10,000 0 - - Stock Option (Right to Buy)
Jeffrey Jacobs Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.64 per share. 03 Aug 2021 5,613 128,438 (0%) 0% 1.6 9,205 Common Stock
Jeffrey Jacobs Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. 03 Aug 2021 10,000 134,051 (0%) 0% 0.5 5,400 Common Stock
Richard J. Rodgers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2021 9,917 87,527 (0%) 0% 0 Common Stock
Richard J. Rodgers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2021 32,765 32,765 - - Stock Option (Right to Buy)
William C. Bertrand Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2021 8,891 83,549 (0%) 0% 0 Common Stock
William C. Bertrand Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2021 32,765 32,765 - - Stock Option (Right to Buy)
David M. Mott Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2021 32,765 32,765 - - Stock Option (Right to Buy)
Jan M. Lundberg Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2021 32,765 32,765 - - Stock Option (Right to Buy)
Jan M. Lundberg Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2021 7,181 42,799 (0%) 0% 0 Common Stock
Robert B. Bazemore Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2021 32,765 32,765 - - Stock Option (Right to Buy)
Geoffrey A. Block Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2021 32,765 32,765 - - Stock Option (Right to Buy)
Onaiza Cadoret-Manier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2021 32,765 32,765 - - Stock Option (Right to Buy)
Jeffrey Jacobs Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jun 2021 7,500 10,000 - - Stock Option (Right to Buy)
Jeffrey Jacobs Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 7.29 per share. 15 Jun 2021 7,500 124,051 (0%) 0% 7.3 54,659 Common Stock
Jeffrey Jacobs Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.54 per share. 15 Jun 2021 7,500 131,551 (0%) 0% 0.5 4,050 Common Stock
David P. Rosenbaum Chief Development Officer 28 May 2021 3,062 26,750 (0%) 0% 7.2 22,098 Common Stock
Justin A. Renz Chief Financial Officer 20 May 2021 612 40,678 (0%) 0% 7.1 4,338 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 7.09 per share. 20 May 2021 2,534 214,754 (0%) 0% 7.1 17,960 Common Stock
David P. Rosenbaum Chief Development Officer 20 May 2021 612 159,435 (0%) 0% 7.1 4,338 Common Stock
David P. Rosenbaum Chief Development Officer 20 May 2021 157 29,812 (0%) 0% 7.1 1,113 Common Stock
Jeffrey Jacobs Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 7.09 per share. 20 May 2021 721 124,051 (0%) 0% 7.1 5,110 Common Stock
Elizabeth Grammer See Remarks 20 May 2021 508 102,912 (0%) 0% 7.1 3,601 Common Stock
Susan Rodriguez Chief Commercial Officer 20 May 2021 611 45,303 (0%) 0% 7.1 4,331 Common Stock
Robert Blanks See Remarks 20 May 2021 612 106,954 (0%) 0% 7.1 4,338 Common Stock
David P. Rosenbaum Chief Development Officer 06 Apr 2021 5,000 160,047 (0%) 0% 8 40,000 Common Stock
Robert Blanks See Remarks 06 Apr 2021 1,826 107,566 (0%) 0% 8 14,608 Common Stock
Robert Blanks See Remarks 06 Apr 2021 3,337 109,392 (0%) 0% 8 26,696 Common Stock
Muna Bhanji Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2021 63,687 63,687 - - Stock Option (Right to Buy)
Justin A. Renz Chief Financial Officer 22 Feb 2021 608 41,290 (0%) 0% 6.9 4,185 Common Stock
Michael G. Raab Director, President & CEO Sale of securities on an exchange or to another person at price $ 6.88 per share. 22 Feb 2021 2,534 217,288 (0%) 0% 6.9 17,440 Common Stock
David P. Rosenbaum Chief Development Officer 22 Feb 2021 193 29,969 (0%) 0% 6.9 1,328 Common Stock
David P. Rosenbaum Chief Development Officer 22 Feb 2021 612 165,047 (0%) 0% 6.9 4,212 Common Stock
Jeffrey Jacobs Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 6.88 per share. 22 Feb 2021 702 124,772 (0%) 0% 6.9 4,832 Common Stock
Elizabeth Grammer See Remarks 22 Feb 2021 504 103,420 (0%) 0% 6.9 3,469 Common Stock
Susan Rodriguez Chief Commercial Officer 22 Feb 2021 611 45,914 (0%) 0% 6.9 4,205 Common Stock
Robert Blanks See Remarks 22 Feb 2021 593 112,729 (0%) 0% 6.9 4,081 Common Stock
Justin A. Renz Chief Financial Officer 05 Jan 2021 146,755 146,755 - - Stock Option (Right to Buy)
Justin A. Renz Chief Financial Officer 05 Jan 2021 32,612 41,898 (0%) 0% 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters